NCT03566615

Brief Summary

This is a study to compare two different, but normally, used methods of colonoscopy in patients that require a routine or repeat colonoscopy. There will be three arms in this study: WE water control, water plus Cap-1, and water plus Cap-2. The patient will prepare himself/herself for the colonoscopy as per normal instructions and he/she will be given the information for the study at that time so that he/she can make a decision to participate in the study. The control method will use water instead of air inserted into the colon. The study method will use a new accessory, a cap that will fit onto the end of the colonoscope plus water during the procedure. This study will also confirm if using the cap method with water is a better way of detecting polyps in the colon and possibly cancer.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,630

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2018

Longer than P75 for not_applicable

Geographic Reach
4 countries

7 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 25, 2018

Completed
6 days until next milestone

Study Start

First participant enrolled

July 1, 2018

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2023

Completed
Last Updated

October 6, 2022

Status Verified

October 1, 2022

Enrollment Period

4.5 years

First QC Date

April 30, 2018

Last Update Submit

October 4, 2022

Conditions

Keywords

colonoscopyadenoma detection ratecaps

Outcome Measures

Primary Outcomes (1)

  • Adenoma detection rate

    The proportion of individuals undergoing a complete screening colonoscopy who have one or more adenomas, or polyps, detected.

    2 years

Secondary Outcomes (5)

  • Cecal intubation

    2 hours: Data collected during colonoscopy procedure

  • Boston bowel preparation score

    2 hours: Data collected during colonoscopy procedure

  • Cecal intubation time

    2 hours: Data collected during colonoscopy procedure

  • Visual analogue scale (0=not satisfied, 10=very satisfied)

    2 hours: Data collected during colonoscopy procedure

  • Willing to repeat

    2 hours: Data collected during colonoscopy procedure

Study Arms (3)

Water

ACTIVE COMPARATOR

Residual air in the colon will be removed, water will be infused to guide insertion through an airless lumen. Infused water will be removed by suction, along with residual fecal debris, predominantly during insertion.

Other: water

CAP-straight

EXPERIMENTAL

A straight transparent cap was fitted to the colonoscope per manufacturer instruction.Residual air in the colon will be removed, water will be infused to guide insertion through an airless lumen. Infused water will be removed by suction, along with residual fecal debris, predominantly during insertion.

Device: CAP-straightOther: water

CAP-daisy

EXPERIMENTAL

A daisy cap transparent cap was fitted to the colonoscope per manufacturer instruction.Residual air in the colon will be removed, water will be infused to guide insertion through an airless lumen. Infused water will be removed by suction, along with residual fecal debris, predominantly during insertion. Note: IRB Approval date for the use of Endocuff at St. Barbara Hospital, Iglesias (CA), Italy, was obtained on 3/8/2017. IRB Approval date for the use of Endocuff at Evergreen General Hospital, Taipei, Taiwan, was obtained on 3/18/2021.

Device: CAP-daisyOther: water

Interventions

This study is to detect any differences in the detection rate of adenomas using straight caps that will be attached to the colonoscope and to compare it to the control method where no cap is used in the colonoscopy procedure.

CAP-straight
CAP-daisyDEVICE

This study is to detect any differences in the detection rate of adenomas using daisy caps that will be attached to the colonoscope and to compare it to the control method where no cap is used in the colonoscopy procedure.

CAP-daisy
waterOTHER

using water instead of traditional air insufflation to help insertion

CAP-daisyCAP-straightWater

Eligibility Criteria

Age50 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female 50-75 yrs of age.
  • Positive screening for Fecal Immunochemical Test (FIT) or Fecal Occult Blood Test (FOBT).
  • Subjects willing to undergo routine screening and surveillance colonoscopy.

You may not qualify if:

  • Patients who decline to provide informed consent.
  • Patients known to have colonic obstruction, inflammatory bowel disease, or active GI bleeding requiring interventions.
  • Patients know to have prior history of severe diverticulitis/diverticulosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Sacramento VAMC, VA Northern California Healthcare System

Mather, California, 95655-4200, United States

RECRUITING

Veterans Affairs Palo Alto Healthcare System

Palo Alto, California, 94550, United States

RECRUITING

Xijing Hospital of Digestive Diseases

Xi'an, 710032, China

RECRUITING

St. Barbara Hospital

Iglesias, Italy

COMPLETED

Dalin Tzu Chi General Hospital

Chiayi City, 622, Taiwan

RECRUITING

Hualien Tzu Chi Hospital

Hualien City, Taiwan

RECRUITING

Evergreen General Hospital

Taipei, Taiwan

RECRUITING

MeSH Terms

Conditions

Colonic PolypsCryopyrin-Associated Periodic Syndromes

Interventions

Water

Condition Hierarchy (Ancestors)

Intestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsHereditary Autoinflammatory DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin Diseases, GeneticSkin DiseasesSkin and Connective Tissue DiseasesChronic Inducible UrticariaChronic UrticariaUrticariaSkin Diseases, VascularCold UrticariaHypersensitivity, ImmediateHypersensitivityImmune System DiseasesChronic DiseaseDisease AttributesPathologic Processes

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Study Officials

  • Felix W Leung, MD

    VA Greater Los Angeles Healthcare System

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Vivek Dixit, PhD

CONTACT

Felix W Leung, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Site PI and Director of Study

Study Record Dates

First Submitted

April 30, 2018

First Posted

June 25, 2018

Study Start

July 1, 2018

Primary Completion

December 31, 2022

Study Completion

January 31, 2023

Last Updated

October 6, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations